Literature DB >> 3157659

Acceptance of hepatitis B vaccine by hospital personnel.

K B Crossley, D N Gerding, R A Petzel.   

Abstract

Personnel at high risk of acquiring hepatitis B in two university-affiliated teaching hospitals were offered immunization against this disease. Of the 1,193 employees, 454 (38%) requested immunization. Individuals who declined or deferred immunization were sent questionnaires requesting the reasons for their decisions. Responses to the questionnaire were received from 487 of 674 personnel (72%). Most respondents (greater than 90%) indicated that they: 1) were aware of being at risk of acquiring hepatitis B, and 2) recognized the potential danger of the disease. A majority of respondents (56%) indicated that they had decided not to be immunized because they wanted to wait until more was known about the vaccine. Concern about specific side effects (eg, Guillain-Barré syndrome or acquired immunodeficiency syndrome) was cited much less often as a reason for declining immunization. Nearly one-fifth of questionnaire respondents either did not know the date of their last tetanus-diphtheria immunization or had not received a booster within the past decade.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3157659     DOI: 10.1017/s0195941700062949

Source DB:  PubMed          Journal:  Infect Control        ISSN: 0195-9417


  5 in total

1.  Hepatitis B vaccination coverage among health-care personnel in the United States.

Authors:  Kathy K Byrd; Peng-jun Lu; Trudy V Murphy
Journal:  Public Health Rep       Date:  2013 Nov-Dec       Impact factor: 2.792

2.  Acceptance of hepatitis B vaccine by medical and surgical residents.

Authors:  M P Harward; D L Kaiser; D S Fedson
Journal:  J Gen Intern Med       Date:  1988 Mar-Apr       Impact factor: 5.128

3.  Motivation for hepatitis B vaccine acceptance among medical and physician assistant students.

Authors:  D J Diekema; K J Ferguson; B N Doebbeling
Journal:  J Gen Intern Med       Date:  1995-01       Impact factor: 5.128

4.  Routine hepatitis B vaccination in a clinic for sexually transmitted diseases.

Authors:  H S Weinstock; G Bolan; J S Moran; T A Peterman; L Polish; A L Reingold
Journal:  Am J Public Health       Date:  1995-06       Impact factor: 9.308

Review 5.  The potential of 1018 ISS adjuvant in hepatitis B vaccines: HEPLISAV™ review.

Authors:  Nelson F Eng; Nitin Bhardwaj; Rebecca Mulligan; Francisco Diaz-Mitoma
Journal:  Hum Vaccin Immunother       Date:  2013-05-31       Impact factor: 3.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.